High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation
(Q28212079)
scientific article (publication date: March 2003)
scientific article (publication date: March 2003)
Language:
Current Data About
High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation
| (P31) |
(Q13442814)
|
||||||||||||||||||||
| (P50) |
(Q47087605)
|
||||||||||||||||||||
| (P304) |
1759-68
|
||||||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||||||
| (P433) |
5
|
||||||||||||||||||||
| (P478) |
101
|
||||||||||||||||||||
| (P577) |
Saturday, March 1, 2003
|
||||||||||||||||||||
| (P1433) |
(Q885070)
|
||||||||||||||||||||
| (P1476) |
"High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation" (language: en)
|
||||||||||||||||||||
| (P2093) |
Bernhard Schiedlmeier
Hannes Klump
Elke Will
Gökhan Arman-Kalcek
Zhixiong Li
Zheng Wang
Andreas Rimek
Jutta Friel
Christopher Baum
Wolfram Ostertag
|